AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,601,000 | -76.7% | 769,325 | -45.6% | 0.22% | -81.7% |
| Q4 2020 | $32,633,000 | +118.4% | 1,413,300 | +33.6% | 1.19% | +54.0% |
| Q3 2020 | $14,942,000 | +868.4% | 1,058,200 | +934.4% | 0.77% | +420.3% |
| Q2 2020 | $1,543,000 | +180.0% | 102,300 | +124.5% | 0.15% | +27.6% |
| Q3 2018 | $551,000 | -29.4% | 45,560 | -8.9% | 0.12% | -62.9% |
| Q2 2018 | $781,000 | -48.1% | 50,000 | -50.0% | 0.31% | -64.8% |
| Q1 2018 | $1,504,000 | -50.1% | 100,000 | -50.0% | 0.89% | +0.7% |
| Q3 2017 | $3,016,000 | +256.9% | 200,000 | +100.0% | 0.88% | +129.7% |
| Q1 2016 | $845,000 | – | 100,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |